Recursion Pharmaceuticals, Inc. announced that the employment of Ramona Doyle, MD as chief medical officer of the Company ended on June 7, 2022. Also, on June 7, 2022, the Company appointed Shafique Virani, MD FRCS, as interim CMO. Dr. Virani continues to also serve as the Company's chief business officer.

Dr. Virani joined the Company in March 2020 and served as its interim CMO until December 2020. Since December 2020, he has served as the Company's chief business officer. Prior to joining the Company, from 2017 to 2019, Dr. Virani served as the chief executive officer of two subsidiaries of BridgeBio LLC, Navire Pharma and CoA Therapeutics, and before that held senior roles in business development at Roche and Genentech from 2006 to 2017.

Dr. Virani also served as a medical director at Roche from 2004 to 2006 in the United Kingdom. Dr. Virani holds an M.D. from the University of Nottingham and trained in neurosurgery at Cambridge, UK, and Boston.